This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:protocol:mp_antibiotics [01.08.2014] – [Mechanisms of action] sallieq | home:protocol:mp_antibiotics [02.12.2014] – [Science behind Marshall Protocol antibiotics] sallieq | ||
---|---|---|---|
Line 2: | Line 2: | ||
====== Science behind Marshall Protocol antibiotics | ====== Science behind Marshall Protocol antibiotics | ||
- | NOTE: Antibotics | + | **NOTE: Antibiotics |
Line 45: | Line 45: | ||
- | ==== Inhibition of bacterial ribosome activity (minocycline, azithromycin, clindamycin, | + | ==== Inhibition of bacterial ribosome activity (minocycline, |
All the MP antibiotics except Bactrim are bacteriostatic. Bacteriostatic antibiotics are a class of antibiotics that work by disabling bacterial ribosomes – small, dense, structures that allow the pathogens to replicate and survive. When an antibiotic binds to a bacterial ribosome, it limits the growth of bacteria by interfering with bacterial protein production, DNA replication, | All the MP antibiotics except Bactrim are bacteriostatic. Bacteriostatic antibiotics are a class of antibiotics that work by disabling bacterial ribosomes – small, dense, structures that allow the pathogens to replicate and survive. When an antibiotic binds to a bacterial ribosome, it limits the growth of bacteria by interfering with bacterial protein production, DNA replication, |